Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

LEPTOSPIRA SP - ANVISA Registration 81816720070

Access comprehensive regulatory information for LEPTOSPIRA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81816720070 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Sep 23, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including INSTITUT VIRION\SERION GMBH, HANGZHOU ALLTEST BIOTECH CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81816720070
2 Related Devices
Registration Details
ANVISA Registration Number: 81816720070
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

LEPTOSPIRA VIRCLIA® IgM MONOTEST
Risk Class III

Registration Details

81816720070

25351767976202310

31167508000102

Company Information

Dates and Status

Sep 23, 2024

23/09/2034

09/18/2025 19:00:01

LEPTOSPIRA VIRCLIA® IgM MONOTEST
Risk Class III

Registration Details

81816720070

25351767976202310

31167508000102

Dates and Status

Sep 23, 2024

23/09/2034

09/18/2025 19:00:01